Alterations in 8-hydroxy-2-(dipropylamino)tetralin-induced neuroendocrine responses after 5,7-dihydroxytcyptamine-induced denervation of serotonergic neurons

Journal of Pharmacology and Experimental Therapeutics

Volumn 286, Issue 1, 1998, Pages 256-262

  Van De Kar, Louis D ^a   Li, Qian ^c   Cabrera, Theresa M ^d   Brownfield, Mark S ^b   Battaglia, George ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 5,7 DIHYDROXYTRYPTAMINE; CORTICOSTERONE; CORTICOTROPIN; OXYTOCIN; PAROXETINE; PROLACTIN; RENIN; SEROTONIN 1 AGONIST; SEROTONIN 1A RECEPTOR; VASOPRESSIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; DENERVATION; HYPOTHALAMUS; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; NEUROENDOCRINOLOGY; NONHUMAN; OXYTOCIN BLOOD LEVEL; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; RAT; SEROTONINERGIC NERVE CELL; SUBCUTANEOUS DRUG ADMINISTRATION; VASOPRESSIN BLOOD LEVEL;

5,7-DIHYDROXYTRYPTAMINE; 8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ADRENOCORTICOTROPIC HORMONE; ANIMALS; DENERVATION; HYPOTHALAMUS; MALE; OXYTOCIN; PROLACTIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN AGONISTS; VASOPRESSINS;

EID: 0031849606     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Aulakh CS, Wozniak KM, Haas M, Hill JL, Zohar J and Murphy DL (1988) Food intake, neuroendocrine and temperature effects of 8-OHDPAT in the rat. Eur J Pharmacol 146:253-259.
2. 2C receptor-mediated oxytocin, prolactin and ACTH/corticosterone responses. Behav Brain Res 73:277-280.
3. Bagdy G, Calogero AE, Murphy DL and Szemeredi K (1989) Serotonin agonists cause parallel activation of the sympathoadrenomedullary system and the hypothalamo-pituitary-adrenocortical axis in conscious rats. Endocrinology 125:2664-2669.
4. 1C receptors induce oxytocin release in the male rat. Brain Res 611:330-332.
5. 2 receptor agonist-induced oxytocin, prolactin, and corticosterone responses. Endocrinology 134:1127-1131.
6. Bagdy G, Sved AF, Murphy DL and Szemeredi K (1992) Pharmacological characterization of serotonin receptor subtypes involved in vasopressin and plasma renin activity responses to serotonin agonists. Eur J Pharmacol 210:285-289.
7. Battaglia G (1990) Criteria for assessing drug-induced biochemical alterations and degeneration of serotonergic neurons. In Serotonin: From Cell Biology to Pharmacology and Therapeutics, ed. by R. Paoletti, P. M. Vanhoutte, N. Brunello and F. M. Maggi, pp. 651-660, Kluwer Academic Publishers, Dordrecht, The Netherlands.
8. 1A receptor-mediated neuroendocrine responses in male but not female rat progeny after prenatal cocaine: Evidence for gender differences. J Pharmacol Exp Ther 271:1453-1461.
9. Battaglia G, Sharkey J, Kuhar MJ and De Souza EB (1991) Neuroanatomic specificity and time course of alterations in rat brain serotonergic pathways induced by MDMA (3,4-methylenedioxymethamphetamine): Assessment using quantitative autoradiography. Synapse 8:249-260.
10. 3H]paroxetine-labeled serotonin uptake sites. J Pharmacol Exp Ther 242:911-916.
11. 1A agonist, on ACTH and PRL secretion in the rat. Neuroendocrinology 61:159-166.
12. Brownfield MS, Greathouse J, Lorens SA, Armstrong J, Urban JH and Van de Kar LD (1988) Neuropharmacological characterization of serotoninergic stimulation of vasopressin secretion in conscious rats. Neuroendocrinology 47:277-283.
13. Carlsson M and Eriksson E (1986) A central serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino) tetralin, has different effects on prolactin in male and female rats. Acta Pharmacol. Toxicol. 58:297-302.
14. Carter DA and Murphy D (1989) Independent regulation of neuropeptide mRNA level and poly(A) tail length. J Biol Chem 264:6601-6603.
15. 1A receptor antagonist WAY100635. Eur J Pharmacol 264:95-97.
16. Dechant KL and Clissold SP (1991) Paroxetine: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness. Drugs 41:225-253.
17. 3H]Paroxetine binding and serotonin content of rat and rabbit cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region. Synapse 9:14-26.
18. Di Sciullo A, Bluet Pajot MT, Mounier F, Oliver C, Schmidt B and Kordon C (1990) Changes in anterior pituitary hormone levels after serotonin 1A receptor stimulation. Endocrinology 127:567-572.
19. Engeland WC, Byrnes GJ, Presnell K and Gann DS (1981) Adrenocortical sensitivity to adrenocorticotropin (ACTH) in awake dogs changes as a function of the time of observation and after hemorrhage independently of changes in ACTH. Endocrinology 108:2149-2153.
20. Feldman S, Conforti N and Melamed E (1987) Paraventricular nucleus serotonin mediates neurally stimulated adrenocortical secretion. Brain Res Bull. 18:165-168.
21. 1A receptor antagonist. Behav Brain Res 73:337-353.
22. Frankfurt M, Mendelson SD, McKittrick CR and McEwen BS (1993) Alterations of serotonin receptor binding in the hypothalamus following acute denervation. Brain Res 601:349-352.
23. Frankfurt M, McKittrick CR, Mendelson SD and McEwen BS (1994) Effect of 5,7-dihydroxytryptamine, ovariectomy and gonadal steroids on serotonin receptor binding in rat brain. Neuroendocrinology 59:245-250.
24. Gotoh E, Murakami K, Bahnson TD and Ganong WF (1987) Role of brain serotonergic Pathways and hypothalamus in regulation of renin secretion. Am J Physiol 253:R179-R185.
25. 1A receptor regulation: Effect of 5,7-dihydroxytryptamine and antidepressant treatments. Neuropsychopharmacology 4:131-144.
26. Iovino M and Steardo L (1985) Effect of substances influencing brain serotonergic transmission on plasma vasopressin levels in the rat. Eur J Pharmacol 113:99-103.
27. Kaneko M, Hiroshige T, Shinsako J and Dallman MF (1980) Diurnal changes in amplification of hormone rhythm in the adrenocortical system. Am J Physiol 239:R309-R316.
28. Kaneko M, Kaneko K, Shinsako J and Dallman MF (1981) Adrenal sensitivity to adrenocorticotropin varies diurnally. Endocrinology 109:70-75.
29. Kawano S, Osaka T, Kannan H and Yamashita H (1992) Excitation of hypothalamic paraventricular neurons by stimulation of the raphe nuclei. Brain Res Bull 28: 573-579.
30. 1A receptors increases release of prolactin in the rat. Neuropharmacology 31:643-647.
31. 2 receptors. Mol Pharmacol 42:328-335.
32. 1A receptors in the rat brain: Lack of effect by repeated injections of fluoxetine. Brain Res 769:141-151.
33. 1A agonist ipsapirone by long-term treatment with fluoxetine, but not desipramine, in male rats. Biol Psychiatry 36:300-308.
34. 1A agonist 8-OH-DPAT in male rats. Brain Res 630:148-156.
35. 1A receptors. J Pharmacol Exp Ther 282:1581-1590.
36. Liposits Z, Phelix C and Paull WK (1987) Synaptic interaction of serotonergic axons and corticotropin releasing factor (CRF) synthesizing neurons in the hypothalamic paraventricular nucleus of the rat: A light and electron microscopic immunocytochemical study. Histochemistry 86:541-549.
37. 2) agonists and antagonists on renin and corticosterone secretion. Neuroendocrinology 46:305-310.
38. Lowry OH, Rosebrough WY, Farr AL and Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
39. Manias B and Taylor DA (1983) Inhibition of in vitro uptake into rat brain synaptosomes after in vivo administration of antidepressants. Eur J Pharmacol 96:305-309.
40. 1A receptormediated regulation of plasma neuroendocrine hormones. J Pharmacol Exp Ther 271:1246-1252.
41. 1A receptor mRNA in the rat brain. Mol Brain Res 14:357-362.
42. Moos F and Richard P (1983) Serotonergic control of oxytocin release during suckling in the rat: Opposite effects in conscious and anesthetized rats. Neuroendocrinology 36:300-306.
43. 1A receptor subtype in the paraventricular nuclei of the hypothalamus induces CRH ACTH release in the rat. Neuroendocrinology 56:797-802.
44. Pergola PE, Sved AF, Voogt JL and Alper RH (1993) Effect of serotonin on vasopressin release: A comparison to corticosterone, prolactin and renin. Neuroendocrinology 57:550-558.
45. Pileblad E and Carlsson A (1985) catecholamine-uptake inhibitors prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mouse brain. Neuropharmacology 24:689-692.
46. Poland RE (1990) Diminished corticotropin and enhanced prolactin responses to 8-hydroxy-2(di-n-propylamino)tetralin in methylenedioxymethamphetamine pretreated rats. Neuropharmacology 29:1099-1101.
47. 1A sites and 5-HT transporter sites. Neurochem Res 19:311-315.
48. 2A/2C) receptors. J Pharmacol Exp Ther 271:1647-1655.
49. 1A agonist, in three stress paradigms: Immobilization, forced swim and conditioned fear. Brain Res 580:205-214.
50. 1C/2 receptors. Endocrinology 133:661-667.
51. Rittenhouse PA, Li Q, Levy AD and Van de Kar LD (1992b) Neurons in the hypothalamic paraventricular nucleus mediate the serotonergic stimulation of renin secretion. Brain Res 593:105-113.
52. Saphier D (1991) Paraventricular nucleus magnocellular neuronal responses following electrical stimulation of the midbrain dorsal raphe. Exp Brain Res 85:359-363.
53. Saydoff JA, Carnes M and Brownfield MS (1993) The role of serotonergic neurons in intravenous hypertonic saline-induced secretion of vasopressin, oxytocin, and ACTH. Brain Res Bull 32:567-572.
54. Saydoff JA, Rittenhouse PA, Carnes M, Armstrong J, Van de Kar LD and Brownfield MS (1996) Neuroendocrine and cardiovascular effects of serotonin: selective role of brain angiotensin on vasopressin. Am J Physiol 270:E513-E521.
55. Saydoff JA, Rittenhouse PA, Van de Kar LD and Brownfield MS (1991) Enhanced serotonergic transmission stimulates oxytocin secretion in conscious male rats. J Pharmacol Exp Ther 267:95-99.
56. 1A receptor activation by flesinoxan in humans: Body temperature and neuroendocrine responses. Neuropsychopharmacology 13:93-104.
57. Shimizu H, Tatsuno T, Tanaka H, Hirose A, Araki Y and Nakamura M (1992) Serotonergic mechanisms in anxiolytic effect of tandospirone in the Vogel conflict test. Jpn J Pharmacol 59:105-112.
58. 7 receptor binding sites in rat hypothalamus: Sensitivity to chronic antidepressant treatment. Mol Pharmacol 47:99-103.
59. Steel RGD and Torrie JH (1960) Principles and Procedures of Statistics with Special Reference to the Biological Sciences, McGraw-Hill, New York.
60. Van de Kar LD (1997) 5-HT receptors involved in the regulation of hormone secretion. In Handbook of Experimental Pharmacology: Serotoninergic Neurons and 5-HT Receptors, ed. by H. G. Baumgarten and M. Göthert, pp. 537-562, Springer, Berlin.
61. Van de Kar LD, Carnes M, Maslowski RJ, Bonadonna AM, Rittenhouse PA, Kunimoto K, Piechowski RA and Bethea CL (1989) Neuroendocrine evidence for denervation supersensitivity of serotonin receptors: Effects of the 5-HT agonist RU 24969 on corticotropin, corticosterone, prolactin and renin secretion. J Pharmacol Exp Ther 251:428-434.
62. Van de Kar LD, Rittenhouse PA, Li Q, Levy AD and Brownfield MS (1995) Hypothalamic paraventricular, but not supraoptic neurons, mediate the serotonergic stimulation of oxytocin secretion. Brain Res Bull 36:45-50.
63. Van de Kar LD, Wilkinson CW and Ganong WF (1981) Pharmacological evidence for a role of brain serotonin in the maintenance of plasma renin activity in unanesthetized rata. J Pharmacol Exp Ther 219:85-90.
64. Van de Kar LD, Urban JH and Brownfield MS (1990) Serotonergic regulation of renin and vasopressin secretion. In Serotonin: From Cell Biology to Pharmacology and Therapeutics, ed. by R. Paoletti, P. M. Vanhoutte, N. Brunello and F. M. Maggi, pp. 123-129, Kluwer Academic Publishers, Dordrecht, The Netherlands.
65. Van de Kar LD, Urban JH, Lorens SA and Richardson KD (1985) The non-benzodiazepine anxiolytic buspirone inhibits stress-induced renin secretion and lowers heart rate. Life Sci 36:1149-1155.
66. Van Wijngaarden I, Tulp MTM and Soudijn W (1990) The concept of selectivity in 5-HT receptor research. Eur J Pharmacol 188:301-312.
67. 1A antagonist WAY-100635 inhibits the 8-OH-DPAT induced increase in plasma ACTH, corticosterone and oxytocin but not prolactin. Soc Neurosci Abstr 22:1326.
68. 5B receptor couples to a G protein in mammalian cell membranes. FEBS Lett 333:25-31.